Last reviewed · How we verify

NCT07090187

Novel Assistive Device and Functional Electrical Stimulation Therapy

Not yet recruiting NA Last updated 29 July 2025
What this trial tests

NA trial testing LegoPress , Novel assistive device in Rehabilitation in 10 participants. Not yet recruiting.

Timeline
15 August 2025
Primary endpoint
15 May 2026
3 June 2026

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposedevice feasibility
Enrollment10
Start date15 August 2025
Primary completion15 May 2026
Estimated completion3 June 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 70, any sex, with Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke causes neurological deficits, impacting walking, balance, strength, and independence, with high mortality and economic burden. Moreover, it brings serious mental and economic stress to patients and their families because of loss of independence. Current rehabilitation methods include standard therapy and electrical stimulation. This study introduces a novel hybrid approach combining use of an assistive device, the LegoPress, paired with closed-loop functional electrical stimulation for subacute stroke patients' lower limbs in a seated position, aiming to improve motor function particularly gait and balance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07090187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing